tirzepatide pakistan #getzpharma #businessdevelopment #pakistan #glp #diabetes #obesity #innovation Tirzepatide in Pakistan: A Revolutionary

Mounjaro for weight loss Although Mounjaro is only FDA-approved for treatment of type 2 diabetes, some healthcare providers may prescribe it off-label for weight management in adults with obesity or overweight, combined with a healthy diet and exercise routine

Finally, any uncertainty about symptom interpretation or management warrants provider consultation

[Crossref] [Google Scholar] [PubMed] Wadey K, Lopes J, Bendeck M, George S

Patients often report nausea, vomiting, diarrhea, constipation, or stomach pain

[DOI] [PMC free article] [PubMed] [Google Scholar] [13].Pouliot M-C, Desprs J-P, Nadeau A, et al

10.1016/j.molcel.2013.08.003 64 JiahuiW.XiangY.YouhuanZ.XiaominM.YuanzhuG.DejianZ.et al (2025)